Bohai Pharmaceuticals Group, Inc. Receivables Turnover Ratio (BOPH), from the first quarter 2015 to the first quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bohai Pharmaceuticals Group, Inc.  (BOPH)
 

Bohai Pharmaceuticals Group Accounts Receivables Turnover Ratio from the first quarter 2015 to the first quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Bohai Pharmaceuticals Group, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2015 to a ratio of 4.17, this represents a new company high. This is a clear indication for improving liquidity at Bohai Pharmaceuticals Group, Inc.'s clients. Average receivable collection period, for the Bohai Pharmaceuticals Group in Sep 30 2014 quarter, has decreased to 88 days, compared to 91 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 268 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1141 to 2913.

What is Receivable Turnover Ratio?
What is Bohai Pharmaceuticals Group, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BOPH Receivables Turnover Ratio (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Receivable Change -8.07 % 7.57 % 13.41 % 7.05 % 21.6 %
Y / Y Revenue Change 7.57 % 12.47 % 14.19 % -5.52 % 43.96 %
Receivable Turnover Ratio (TTM) 4.17 4 3.95 3.96 4.09
BOPH's Total Ranking # 2913 # 1141 # 2810 # 1174 # 2467
Accounts Receivable average collection period days 88 91 92 92 89
Seq. Receivable Change -9.5 % -10.43 % 1.32 % 11.93 % 5.9 %
Seq. Revenue Change 19.52 % 15.31 % 2.71 % -24 % 24.96 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 269
Overall Market # 2913

Receivable Turnover Ratio Statistics
High Average Low
4.17 3.82 2.69
(Sep 30 2014)   (Mar 31 2012)





BOPH Company Profile • Back to BOPH Efficiency Comparisons • Compare BOPH Receivables Turnover Ratio to its Competitors

Financial Statements
Bohai Pharmaceuticals Group's Accounts Receivable $ 38 Millions Visit BOPH's Balance sheet
Bohai Pharmaceuticals Group's Sales TTM $ 179 Millions Visit BOPH's Income Statement
Sources of BOPH's Revenues Visit BOPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BOPH's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BOPH's Growth Rates BOPH's Roa BOPH's Inventory Turnover Ratio BOPH's Dividend Comparisons
BOPH's Profitability Ratios BOPH's Roi BOPH's Asset Turnover Ratio BOPH's Dividend Growth
BOPH's Valuation Ratios BOPH's Roe BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Dyax Corp  12.66 $ 72.554  Millions$ 5.730  Millions
Insite Vision Inc  12.61 $ 8.930  Millions$ 0.708  Millions
Musclepharm Corporation  12.58 $ 182.210  Millions$ 14.485  Millions
Rockwell Medical inc   12.57 $ 53.705  Millions$ 4.272  Millions
Imunon Inc   12.36 $ 0.500  Millions$ 0.040  Millions
Tandem Diabetes Care Inc   12.16 $ 42.079  Millions$ 3.462  Millions
Hca Healthcare Inc   12.12 $ 65,737.000  Millions$ 5,423.250  Millions
Strata Skin Sciences Inc  12.05 $ 0.680  Millions$ 0.056  Millions
Alaunos Therapeutics Inc   11.97 $ 1.233  Millions$ 0.103  Millions
Immucell Corporation  11.86 $ 6.951  Millions$ 0.586  Millions
Apyx Medical Corp  11.86 $ 26.343  Millions$ 2.222  Millions
Noho, Inc.  11.83 $ 1.177  Millions$ 0.100  Millions
Merrimack Pharmaceuticals Inc  11.28 $ 76.674  Millions$ 6.796  Millions
First Choice Healthcare Solutions Inc   11.27 $ 20.262  Millions$ 1.797  Millions
Aspira Women s Health inc   11.19 $ 2.548  Millions$ 0.228  Millions
Procyon Corporation  11.18 $ 2.726  Millions$ 0.244  Millions
Surmodics Inc   11.13 $ 57.439  Millions$ 5.162  Millions
Encision Inc   10.93 $ 9.975  Millions$ 0.913  Millions
Amedisys Inc  10.88 $ 1,197.600  Millions$ 110.069  Millions
Arbutus Biopharma Corp  10.88 $ 13.566  Millions$ 1.247  Millions
Corindus Vascular Robotics, Inc.  10.75 $ 1.292  Millions$ 0.120  Millions
Neurometrix Inc   10.66 $ 5.505  Millions$ 0.517  Millions
Dendreon Corp  10.61 $ 298.949  Millions$ 28.166  Millions
Genmark Diagnostics Inc   10.60 $ 27.219  Millions$ 2.568  Millions
American Caresource Holdings, Inc.  10.52 $ 23.952  Millions$ 2.277  Millions
National Healthcare Corp  10.43 $ 852.105  Millions$ 81.680  Millions
Corcept Therapeutics Inc  10.41 $ 21.653  Millions$ 2.080  Millions
Champions Oncology Inc   10.29 $ 9.941  Millions$ 0.966  Millions
Heartbeam Inc   10.24 $ 156.030  Millions$ 15.238  Millions
Sanuwave Health Inc   10.12 $ 0.901  Millions$ 0.089  Millions

Date modified: 2026-09-12T06:21:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.